Key Metrics
7.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.88
5-Year SI
5-year SI
- N/A 2-year SI
- 0.86 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Oncology
SJR
- Q1 Oncology
- Q2 Cancer Research
- Q1 Pharmacology (medical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.03
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Epidermal growth factor receptor
- Lung cancer
- P53 expression
- Progression-free survival
- Breast cancer
- Hepatocellular carcinoma
- Crizotinib
- Copanlisib
- Overall survival
- Pembrolizumab
- Confidence interval
- Adenocarcinoma
- Objective response
- Colorectal cancer
- Mutation testing
- Cerebrospinal fluid
- Immunotherapy
- Metastatic breast cancer
- Melanoma
- Erlotinib
Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Targeted Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma
- 1 Nov 23
- Targeted Oncology
-
Full paper
Trastuzumab Deruxtecan: A Review in Unresectable or Metastatic HER2-Positive Breast Cancer
- 1 May 23
- Targeted Oncology
-
Full paper
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer
- 21 Apr 23
- Targeted Oncology
-
Full paper
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
- 1 Mar 23
- Targeted Oncology
-
Full paper
Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
- 1 Mar 23
- Targeted Oncology
-
Full paper
Acknowledgement to Referees
- 1 Nov 22
- Targeted Oncology
Scite analysis
Powered by scite_
1k articles received 14k citations see all
- 419 Supporting
- 13,253 Mentioning
- 64 Contrasting
Editorial notices
- 4 Retractions
- 0 Withdrawals
- 35 Corrections
- 36 Errata
- 0 Expression of Concern
FAQs
How long has Targeted Oncology been actively publishing?
Targeted Oncology has been in operation since 2006 till date.
What is the publishing frequency of Targeted Oncology ?
Targeted Oncology published with a Bi-monthly frequency.
How many articles did Targeted Oncology publish last years ?
In 2023, Targeted Oncology published 5 articles.
What is the eISSN & pISSN for Targeted Oncology ?
For Targeted Oncology,eISSN is 1776-260X and pISSN is1776-2596.
What is Citescore for Targeted Oncology ?
Citescore for Targeted Oncology is 7.2.
What is SNIP score for Targeted Oncology ?
SNIP score for Targeted Oncology is 1.03.
What is the SJR for Targeted Oncology ?
SJR for Targeted Oncology is Q2.
Who is the publisher of Targeted Oncology ?
SPRINGER is the publisher of Targeted Oncology.